Discounted Cash Flow (DCF) Analysis Unlevered

China Health Industries Holdings, I... (CHHE)

$0.14

0.00 (0.00%)
All numbers are in Millions, Currency in USD
Stock DCF: 0.59 | 0.14 | undervalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 6.559.289.936.49000000
Revenue (%)
EBITDA 0.665.515.823.040.640.100.080.060.050.04
EBITDA (%)
EBIT -04.695.022.16-0.19-0.03-0.02-0.02-0.01-0.01
EBIT (%)
Depreciation 0.670.820.810.880.830.130.100.080.060.05
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 32.6135.5136.0744.3544.797.035.524.333.402.67
Total Cash (%)
Account Receivables 1.492.024.662.380.040.010.01000
Account Receivables (%)
Inventories 0.450.860.810.760.520.080.060.050.040.03
Inventories (%)
Accounts Payable 0.400.500.410.410.330.050.040.030.030.02
Accounts Payable (%)
Capital Expenditure -0.41-0.15-0.16-0.01-0-0-0-0-0-0
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.14
Beta -9.431
Diluted Shares Outstanding 65.54
Cost of Debt
Tax Rate -0.84
After-tax Cost of Debt 2.32%
Risk-Free Rate
Market Risk Premium
Cost of Equity -40.732
Total Debt 6.76
Total Equity 9.18
Total Capital 15.94
Debt Weighting 42.42
Equity Weighting 57.58
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 6.559.289.936.49000000
EBITDA 0.665.515.823.040.640.100.080.060.050.04
EBIT -04.695.022.16-0.19-0.03-0.02-0.02-0.01-0.01
Tax Rate -489.31%29.50%29.23%36.13%-0.84%-79.06%-79.06%-79.06%-79.06%-79.06%
EBIAT -0.033.313.551.38-0.20-0.05-0.04-0.03-0.03-0.02
Depreciation 0.670.820.810.880.830.130.100.080.060.05
Accounts Receivable --0.53-2.652.282.340.030000
Inventories --0.400.050.050.240.440.020.010.010.01
Accounts Payable -0.10-0.090-0.07-0.28-0.01-0.01-0.01-0.01
Capital Expenditure -0.41-0.15-0.16-0.01-0-0-0-0-0-0
UFCF 0.243.131.514.573.140.270.070.050.040.03
WACC
PV UFCF 0.350.110.110.110.12
SUM PV UFCF 0.80

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -22.47
Free cash flow (t + 1) 0.03
Terminal Value -0.14
Present Value of Terminal Value -0.48

Intrinsic Value

Enterprise Value 0.32
Net Debt -38.03
Equity Value 38.35
Shares Outstanding 65.54
Equity Value Per Share 0.59